Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Samsara Biocapital, Llc
Form 13F · Q2 2026

Samsara Biocapital, Llc

CIK 1744967Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$1.2B
Reported book value
24
Positions
12
Quarters on record
Top 50
Positions

Samsara Biocapital, Llc — holdings

Top 24 positions of 24, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1SRRK Scholar Rock Hldg Corp6.9M+0.0%$379M31.2%
2ALMS Alumis Inc6.3M+0.0%$179M14.7%
3MLYS Mineralys Therapeutics Inc5.9M+0.0%$158M13.0%
4SEPN Septerna Inc3.1M+0.0%$105M8.7%
5ALMR Alamar Biosciences Inc2.5M—$67M5.5%
6NGNE Neurogene Inc1.7M+0.0%$54M4.4%
7KLRS Kalaris Therapeutics Inc12.9M−0.5%$52M4.3%
8SGP Spyglass Pharma Inc2.1M+0.0%$47M3.9%
9STRO Sutro Biopharma Inc1.1M+0.0%$35M2.9%
10IVA Inventiva Sa6.3M+21.6%$24M2.0%
11JBIO Jade Biosciences Inc736,237−24.0%$16M1.3%
12PBLS Parabilis Medicines Inc556,044—$15M1.3%
13VTVT Vtv Therapeutics Inc298,496+0.0%$11M0.9%
14AQST Aquestive Therapeutics Inc2.5M+0.0%$10M0.9%
15NKTX Nkarta Inc3.5M+0.0%$10M0.8%
16ARTV Artiva Biotherapeutics Inc954,861—$9M0.8%
17RANI Rani Therapeutics Hldgs Inc10.4M+22.0%$8M0.6%
18AGMB Agomab Therapeutics Nv600,000+0.0%$8M0.6%
19ABIVAX SA Abivax Sa55,095−2.6%$7M0.6%
20XFOR X4 Pharmaceuticals Inc1.4M−23.8%$7M0.5%
21ELOX Eloxx Pharmaceuticals Inc400,000—$6M0.5%
22CHRS Coherus Oncology Inc3.4M+0.0%$5M0.4%
23UPB Upstream Bio Inc353,717−51.9%$2M0.2%
24GOSS Gossamer Bio Inc7.2M+0.0%$1M0.1%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.